Executive Summary Europe Molecular Diagnostics Market : The molecular diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.5% in the forecast period of 2021 to 2028 and is expected to reach USD 13,637.22 million by 2028. Increase in prevalence of infectious diseases...

MarkNtel Advisors recently published a detailed industry analysis of the Global Molecular Diagnostics (MDx) Point of Care Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market. Global Molecular Diagnostics (MDx) Point of Care Market, Share, and Trends Analysis Report – Industry Overview and Forecast...

According to the UnivDatos, The molecular diagnostics market was valued at approximately USD 16.15 billion in 2024 and is expected to grow at a substantial CAGR of around 7.3% during the forecast period (2025-2033), owing to the rising demand for early and accurate disease detection.The global Molecular Diagnostics market has several major players, including Abbott, BD,...

  The global PCR and real-time PCR molecular diagnostics market is predicted to progress at a CAGR of 4.1% from 2023 to 2033. The market is valued at US$ 5 billion in 2023 and is thereby expected to reach US$ 7.5 billion by 2033-end. The PCR and Real-Time PCR molecular diagnostics market is a critical segment of the broader diagnostics industry. PCR amplifies specific DNA...

The Polymerase Chain Reaction (PCR) and Real-Time PCR Molecular Diagnostics Market has experienced significant growth in recent years, driven by advancements in molecular biology, increasing demand for rapid and accurate diagnostic tools, and the rising prevalence of infectious diseases and genetic disorders. This analysis delves into the market dynamics, key drivers, challenges, and...

Point of Care Molecular Diagnostics Market Overview The global point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 8.2%. This growth is attributed to the increasing incidence of infectious diseases, rising awareness among patients and healthcare professionals, technological advancements in molecular...

"Executive Summary Single Cell Genomics and Proteomics Market : CAGR Value The global single cell genomics and proteomics market was valued at USD 4.66 billion in 2024 and is expected to reach USD 14.78 billion by 2032During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 15.50%, primarily driven by the rising demand for personalized medicine An...